Eric Shiozaki

Eric Shiozaki is a partner at DCVC Bio and has over 10 years of experience in the venture capital and biotech industries. Eric has a Bachelor of Science in Molecular, Cell, and Developmental Biology from UCLA and a Masters in Business Administration from UC Berkeley. Prior to joining DCVC, Eric was a Principal at Novo Ventures, a Director at Apposite Capital, and a Corporate Development and Strategy Consultant at Vitapath Genetics. Eric began their career as an Associate at Burrill & Company and Technology Transfer Associate at UCLA. Eric is also a Leukemia and Lymphoma Society Fellow.

Eric Shiozaki has a doctorate from Princeton University and a bachelor's from the Johns Hopkins University.

Eric Shiozaki reports to John Hamer, Managing Partner, DCVC Bio. Eric Shiozaki works with Anna Fokina - Investment Director, DCVC Bio, Andy May - Entrepreneur In Residence, DCVC Bio, and Christopher Meldrum - Entrepreneur In Residence, DCVC Bio.